Catalog Number:
E45K54208M3-100Amount:
100 ugCite ID#:
EN5424298Price:
941$Type:
Recombinant ProteinsProtein length:
A DNA sequence encoding the cynomolgus TNFSF8 (G7P2F1) (Gln63-Asp234) was expressed, with the Fc region of human IgG1 at the N-terminus.Expression Host:
HEK293 CellsSpecies:
CynomolgusAmino acid sequence:
Gln63-Asp234Tag:
N-hFcMolecular Weight:
The recombinant cynomolgus TNFSF8 is a disulfide-linked homodimer. The reduced monomer comprises 432 amino acids and has a calculated molecular mass of 48.1 KDa.The apparent molecular mass of the protein is approximately 59 KDa respectively in SDS-PAGE.Activity:
Immobilized Cynomolgus Fc-TNFSF8 at 10 μg/ml (100 μl/well) can bind biotinylated human CD30-Fch (Cat:10777-H03H), The ECof biotinylated human CD30-Fch (Cat:10777-H03H) is 5.3-12.5 ng/ml.Endotoxin:
< 1.0 EU per μg of the protein as determined by the LAL method.Gene Name:
tumor necrosis factor (ligand) superfamily, member 8Gene symbol:
TNFSF8Swiss-Prot No.:
G7P2F1Function:
TNF Superfamily proteins, CD Molecule proteins, Biological Target proteins, Cytokine Proteins, Growth Factor proteinsSummary:
CD30 ligand (CD30L), also known as CD153 and TNFSF8, is a membrane-associated glycoprotein belonging to the TNF superfamily and TNFR superfamily, and is a specific ligand for CD30/TNFRSF8 originally described as a cell surface antigen and a marker for Hodgkin lymphoma and related hematologic malignancies. CD30L is a type-II membrane glycoprotein expressed on activated T cells, stimulated monocyte-macrophages, granulocytes, eosinophils, and some Burkitt-like lymphoma cell lines. CD30L is capable of transducing signals through CD30 on different CD30+ lymphoma cell lines, and mediates pleiotropic biologic effects including cell proliferation, activation, differentiation, as well as cell death by apoptosis. CD30-CD30 ligand interaction has been suggested to have a pathophysiologic role in malignant lymphomas, particularly Hodgkin disease, large cell anaplastic lymphomas and Burkitt lymphomas, and is also involved in activation and functioning of the T cell-dependent immune response. Thus, CD153 and its receptor CD30 are regarded as therapeutic targets in hematologic malignancies, autoimmune and inflammatory diseases.Form:
LyophilizedPurity:
> 90 % as determined by SDS-PAGE.Storage/Stability:
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.Storage Buffer:
Lyophilized from sterile PBS, pH 7.4.